Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLiontrust Asset Management Regulatory News (LIO)

Share Price Information for Liontrust Asset Management (LIO)

Share Price is delayed by 15 minutes
Get Live Data
310.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (0.322%)
Market Cap: £185.64m
LIO Live PriceLast checked at - London Stock Exchange

Intraday Liontrust Asset Management Share Chart

Statement re update on documents publication

9 Jun 2023 07:00

RNS Number : 1780C
Liontrust Asset Management PLC
09 June 2023
 

THIS ANNOUNCEMENT, INCLUDING THE APPENDICES AND THE INFORMATION CONTAINED IN THEM, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.

 

FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION.

 

LEI: 549300XVXU6S7PLCL855

 

For immediate release

9 June 2023

 

Liontrust Asset Management Plc

("Liontrust" or the "Company")

Update on publication of documents for Proposed Acquisition

 

Further to the announcement by Liontrust dated 4 May 2023 in relation to the proposed acquisition of the entire issued share capital of GAM Holding AG ("GAM"), a global investment management group (the "Proposed Acquisition"), Liontrust provides an update on publication of the circular in relation to the Proposed Acquisition (the "Circular") and the Swiss offer prospectus setting out the terms and conditions of the Proposed Acquisition to the GAM shareholders (the "Swiss Offer Prospectus").

 

The Company had previously stated that it intended to publish the Circular and Swiss Offer Prospectus on 9 June 2023. The Board now expects to publish both the Circular and Swiss Offer Prospectus on or around 13 June 2023.

 

 

For further information please contact:

 

Teneo (Tel: 020 7353 4200, Email: liontrust@teneo.com)

Tom Murray or Stephanie Mackrell

 

Liontrust Asset Management Plc (Tel: 020 7412 1700, Website: liontrust.co.uk)

John Ions: Chief Executive

Vinay Abrol: Chief Financial Officer & Chief Operating Officer

Simon Hildrey: Chief Marketing Officer

David Boyle: Head of Corporate Development

 

Alantra Corporate Finance LLP (Tel: 020 7246 0500)

Lead Financial Adviser

JP McGrath, Jake Delaney, André Chetty

 

Singer Capital Markets Advisory LLP (Tel: 020 7496 3000)

Sole Sponsor, Financial Adviser and Sole Broker

Stephen Howard, Tom Salvesen, Justin McKeegan, Asha Chotai

 

Panmure Gordon (Tel: 020 7886 2500)

Corporate Broking: Stephen Jones

Corporate Advisory: Dominic Morley

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRKVLFBXQLLBBF
Date   Source Headline
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSProposed Acquisition of River Global Holdings Ltd
16th Mar 20267:00 amRNSProposed Acquisition of River Global Holdings Ltd
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:36 amRNSTotal Voting Rights
26th Feb 202611:35 amRNSForm 8.3 - ESSENSYS
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20261:28 pmRNSForm 8.3 - ESSENSYS
25th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20262:29 pmRNSForm 8.3 - ESSENSYS PLC
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20261:46 pmRNSForm 8.3 - Oxford Biomedica Plc
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20262:40 pmRNSForm 8.3 - Kitwave group plc
18th Feb 20262:37 pmRNSForm 8.3 - Oxford Biomedica Plc
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20263:20 pmRNSForm 8.3 - ESSENSYS PLC
17th Feb 20263:19 pmRNSForm 8.3 - KITWAVE GROUP PLC
16th Feb 20262:51 pmRNSForm 8.3 - Oxford Biomedica Plc
13th Feb 202610:13 amRNSHolding(s) in Company
13th Feb 202610:11 amRNSHolding(s) in Company
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 202611:15 amRNSForm 8.3 - KITWAVE GROUP PLC
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 202612:07 pmRNSForm 8.3 - Kitwave Group Plc
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20263:25 pmRNSForm 8.3 - KITWAVE GROUP PLC
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20262:27 pmRNSForm 8.3 - Kitwave group plc
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20264:36 pmRNSForm 8.3 - MIND GYM PLC
4th Feb 20262:19 pmRNSForm 8.3 - KITWAVE GROUP PLC
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20263:23 pmRNSForm 8.3 - KITWAVE GROUP PLC
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20263:56 pmRNSForm 8.3 - KITWAVE GROUP PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.